Moderna
MRNA
#1830
Rank
โ‚ฌ9.29 B
Marketcap
23,79ย โ‚ฌ
Share price
8.67%
Change (1 day)
-43.44%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2025 (TTM): -7,37ย โ‚ฌ

According to Moderna 's latest financial reports the company's current EPS (TTM) is -6,93ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -7,97ย โ‚ฌ an increase over its 2023 EPS that were of -10,63ย โ‚ฌ.

EPS history for Moderna from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-7,37ย โ‚ฌ-7.57%
2024-7,97ย โ‚ฌ-25.04%
2023-10,63ย โ‚ฌ-158.62%
202218,14ย โ‚ฌ-30.25%
202126,01ย โ‚ฌ-1660.82%
2020-1,67ย โ‚ฌ25.32%
2019-1,33ย โ‚ฌ36.87%
2018-0,97ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regulus Therapeutics
RGLS
-0,63ย โ‚ฌ-90.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,52ย โ‚ฌ-194.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,74ย โ‚ฌ-74.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
0,07730ย โ‚ฌ-101.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6,32ย โ‚ฌ-191.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-1,07ย โ‚ฌ-84.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-229.36%๐Ÿ‡บ๐Ÿ‡ธ USA